Topic: Biotech
Dr. Moira Gunn interviews Bruce Jenett, Co-Chair, Global Life Sciences Sector of DLA Piper about his a definition of biotechnology that anyone can understand.
Moira Gunn discusses nanotechnology with Dr. Mike Fisher of Bio Nano Consulting and Tony Cass, professor of chemical biology at the Imperial College, London. They review both its reality and its potential.
Moira speaks with UC Berkeley professor Dara O'Rourke, founder of GoodGuide.com. He tells us what it takes to understand the impact of everything we use, requiring the tracking of the global supply chain.
Dr. Moira Gunn interviews Jay Keasling, Professor of Chemical Engineering and BioEngineering at UC Berkeley and first recipient of the Biotech Humanitarian Award. They discuss the growing worldwide challenge of malaria and a completely new approach which may make it manageable.
In these two interviews, Dr. Moira Gunn reviews the recently concluded International Biotechnology Conference (BIO 2009). She first talks with former Congressman Jim Greenwood, the President of the Biotechnology Industry Organization, sponsor of the conference. She then speaks with Dr. Steve Sherwin, Oncologist & CEO of Cell Genesys and also incoming Chair of the Biotechnology Industry Organization.
Dr. Moira Gunn reviews the recently concluded International Biotechnology Conference (BIO 2009) with David Ewing Duncan, chief correspondent of Biotech Nation.
Moira Gunn interviews Dr. Tony Coles, President and CEO of Onyx Pharmaceuticals, about the challenges to a company that depends on a single drug for business success.
Dr. Moira Gunn talks to JJ Bienaime, President & CEO of BioMarin Pharmaceuticals about the problem of orphan diseases, diseases not yet under research by pharmaceutical companies because of a lack of financial incentive to market new medications for treatment.
Paul Hastings, president and CEO of Oncomed Pharmaceuticals, discusses the controversial topic of cancer stem cells, what he calls the root of the tumor. He also talks about how his company is working with other pharmaceutical companies who are helping with Oncomed's biotech work.
Moira speaks with former Food and Drug Administration Commissioner David Kessler about his book The End of Overeating, in which he discusses what has been invisibly added to the American supply, leaving some of us obese, and many of us, unexpectedly overweight. He tells us the science behind what happens to our brains when we eat food laden with salt, fat and sugar.
